Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The myocyte enhancer factor-2 (MEF2) transcription factor regulates muscle development and calcium-dependent gene expression. MEF2 activity is repressed by class II histone deacetylases (HDACs), which dissociate from MEF2 when phosphorylated on two serine residues in response to calcium signaling. To explore the potential importance of MEF2/HDAC interactions in the heart, we generated transgenic mice expressing a signal-resistant form of HDAC5 under cardiac-specific and doxycycline-inducible regulation. Transgene expression resulted in sudden death in male mice accompanied by loss and morphologic changes of cardiac mitochondria and down-regulation of mitochondrial enzymes. The transcriptional coactivator PGC-1 alpha, a master regulator of mitochondrial biogenesis and fatty acid oxidation, was also down-regulated in response to HDAC5 expression. Examination of the PGC-1 alpha promoter revealed two MEF2-binding sites that mediate transcriptional activation by MEF2 and repression by HDAC5. These findings identify PGC-1 alpha as a key target of the MEF2/HDAC regulatory pathway and demonstrate this pathway's importance in maintenance of cardiac mitochondrial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is required for maintenance of cardiac mitochondrial function and is regulated by MEF2 and HDAC5 [110].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Self-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Self-citationTRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINS
Black, B. L., & Olson, E. N. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.167 · Cited by 1,039
Self-citationA calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., Wu, H., Zhu, W., Bassel-Duby, R., & Williams, R. S. (1998) · Genes & Development · doi:10.1101/gad.12.16.2499 · Cited by 1,011
Self-citationClass II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Self-citationEberharter, A., & Becker, P. B. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf053 · Cited by 948
Cited by
Items 101–200 of 417
The basic helix–loop–helix transcription factor scleraxis regulates fibroblast collagen synthesis
Espira, L., Lamoureux, L., Jones, S. C., Gerard, R. D., Dixon, I., & Czubryt, M. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.03.024 · Cited by 120
Self-citationNegative feedback maintenance of heme homeostasis by its receptor, Rev-erbα
Wu, N., Yin, L., Hanniman, E. A., Joshi, S., & Lazar, M. A. (2009) · Genes & Development · doi:10.1101/gad.1825809 · Cited by 129
“…PGC-1a transcription via functional retinoic acid receptor-related orphan receptor response elements (ROREs) Analysis of the PGC-1a gene promoter region up to 3.1 kb from the transcriptional start site failed to identify functional Rev-erba response elements (Czubryt et al. 2003; data not shown).”
BackgroundInfluentialYuan, Y., Chen, Y., Zhang, P., Huang, S., Zhu, C., Ding, G., Liu, B., Yang, T., & Zhang, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.015 · Cited by 121
“Additionally, repression of PGC-1a expression by a mutant histone deacetylase-5 results in loss or morphological changes of mitochondria and downregulation of mitochondrial enzymes [14].”
Baldelli, S., Aquilano, K., & Ciriolo, M. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.006 · Cited by 127
Sano, M., Tokudome, S., Shimizu, N., Yoshikawa, N., Ogawa, C., Shirakawa, K., Endo, J., Katayama, T., Yuasa, S., Ieda, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703634200 · Cited by 114
Zehnder, T., Petrelli, F., Romanos, J., De Oliveira Figueiredo, E. C., Lewis, T. L., Déglon, N., Polleux, F., Santello, M., & Bezzi, P. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108952 · Cited by 113
AMPK-mediated regulation of transcription in skeletal muscle
McGee, S. L., & Hargreaves, M. (2010) · Clinical Science · doi:10.1042/cs20090533 · Cited by 112
Miura, P., Chakkalakal, J. V., Boudreault, L., Belanger, G., Hebert, R. L., Renaud, J.-M., & Jasmin, B. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp431 · Cited by 112
Tadaishi, M., Miura, S., Kai, Y., Kawasaki, E., Koshinaka, K., Kawanaka, K., Nagata, J., Oishi, Y., & Ezaki, O. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00400.2010 · Cited by 109
van Waveren, C., & Moraes, C. T. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-18 · Cited by 116
Histone deacetylases in cardiovascular and metabolic diseases
Bagchi, R. A., & Weeks, K. L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.003 · Cited by 112
dos Santos, J. M., Moreli, M. L., Tewari, S., & Benite‐Ribeiro, S. A. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.013 · Cited by 118
Sex and Gender Differences in Clinical Medicine
Regitz‐Zagrosek, V., & Seeland, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_1 · Cited by 132
Neuroprotective Effects of Phenylbutyrate Against MPTP Neurotoxicity
Gárdián, G., Yang, L., Cléren, C., Calingasan, N. Y., Klivènyi, P., & Beal, M. F. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:3:235 · Cited by 111
“The MEF2 transcription factor is also directly involved in activating peroxisome proliferator-activated receptor γ-coactivator (PGC1), which plays a critical role in biogenesis of mitochondria (Czubryt et al., 2003).”
BackgroundCowell, R. M., Blake, K. R., & Russell, J. W. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21211 · Cited by 107
“…receptors (Bramlett and Burris, 2002; Kressler et al., 2002; Schre- iber et al., 2004), the thyroid hormone receptor (Zhang et al., 2004), glucocorticoid receptors (Herzig et al., 2001; Yoon et al., 2001), and members of the myocyte enhancing factor 2 (MEF2) family (Czubryt et al., 2003).”
BackgroundRamachandran, B., Yu, G., & Gulick, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707389200 · Cited by 105
The PGC-1 cascade as a therapeutic target for heart failure
Schilling, J. D., & Kelly, D. P. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.021 · Cited by 108
Mitochondrial Metabolic Reprogramming Induced by Calorie Restriction
Martin-Montalvo, A., & de Cabo, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4866 · Cited by 104
Imasawa, T., Obre, E., Bellance, N., Lavie, J., Imasawa, T., Rigothier, C., Delmas, Y., Combe, C., Lacombe, D., Benard, G., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600293r · Cited by 104
The role of cardiac energy metabolism in cardiac hypertrophy and failure
Tuomainen, T., & Tavi, P. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.052 · Cited by 113
Gender modulates cardiac phenotype development in genetically modified mice
DU, X. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.027 · Cited by 104
“In sharp contrast, all female TG mice survived at least over 30 days indicating gender-specificity in response to HDAC5S/A [80].”
BackgroundInfluentialProtein Kinase D1 Stimulates MEF2 Activity in Skeletal Muscle and Enhances Muscle Performance
Kim, M.-S., Fielitz, J., McAnally, J., Shelton, J. M., Lemon, D. D., McKinsey, T. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00189-08 · Cited by 103
Self-citationLack of age-related increase of mitochondrial DNA amount in brain, skeletal muscle and human heart
Frahm, T., Mohamed, S. A., Bruse, P., Gemünd, C., Oehmichen, M., & Meißner, C. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.06.008 · Cited by 107
Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
Eom, G. H., & Kook, H. Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.012 · Cited by 105
Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes
Piantadosi, C. A., & Suliman, H. B. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.01.003 · Cited by 98
Vankoningsloo, S., De Pauw, A., Houbion, A., Tejerina, S., Demazy, C., de Longueville, F., Bertholet, V., Renard, P., Remacle, J., Holvoet, P., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.02848 · Cited by 97
“However, various transcription factors have been identified to control PGC-1 expression in tissues other than liver and among them, ATF-2 in brown adipocytes (Cao et al., 2004), MEF-2 in muscle tissue (Czubryt et al., 2003), and orphan nuclear receptor ERR in brown adipocytes (Wang et al., 2005).”
Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes
Sharma, S., & Taliyan, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.009 · Cited by 100
Oberkofler, H., Linnemayr, V., Weitgasser, R., Klein, K., Xie, M., Iglseder, B., Krempler, F., Paulweber, B., & Patsch, W. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1385 · Cited by 96
“Because MEF2 has been implicated in skeletal muscle GLUT4 expression (5,34), and transcriptional responses of the PGC-1 promoter to MEF2 may play an important role in programs controlling muscle fiber-type conversion (7,8) and cardiac energy production (6), the 1422 site may contribute to the pathogenesis of other dis…”
BackgroundClark, J., & Simon, D. K. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2241 · Cited by 93
Aubert, G., Vega, R. B., & Kelly, D. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.015 · Cited by 102
Brawn for Brains: The Role of MEF2 Proteins in the Developing Nervous System
Shalizi, A., & Bonni, A. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)69009-6 · Cited by 96
Jiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 99
Liu, W., Ruiz‐Velasco, A., Wang, S., Khan, S., Zi, M., Jungmann, A., Camacho‐Muñoz, D., Guo, J., Du, G., Xie, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00664-8 · Cited by 95
Regulation of Mitochondrial Biogenesis and GLUT4 Expression by Exercise
Holloszy, J. O. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100052 · Cited by 85
Mitochondria and Energetic Depression in Cell Pathophysiology
Seppet, E. K., Puurand, M., Peetsalu, A., Gizatullina, Z. Z., Nguyen, H. P., Vielhaber, S., Wussling, M. H. P., Trumbeckaitė, S., Arandarčikaitė, O., Jerzembek, D., et al. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10052252 · Cited by 97
Arany, Z., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800979105 · Cited by 82
What Causes a Broken Heart—Molecular Insights into Heart Failure
Barry, S. P., & Townsend, P. A. (2010) · International review of cytology · doi:10.1016/s1937-6448(10)84003-1 · Cited by 84
Review: Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation.
Fosslien, E. (2003) · PubMed · Cited by 92
Exercise, redox homeostasis and the epigenetic landscape
Dimauro, I., Paronetto, M. P., & Caporossi, D. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101477 · Cited by 82
“In addition to the redoxsensitive post-translational modification of PGC1α exerted by SIRT1, PGC1α gene expression seems to be modulated through promoter hypermethylation [115,152], as well as via class I and class II histone deacetylases (HDACs) that, in addition to prevent the acetylation on PGC1α promoter area, als…”
BackgroundAnderson, C. M., Hu, J., Barnes, R. M., Heidt, A. B., Cornelissen, I., & Black, B. L. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0031-0 · Cited by 77
Exercise-induced PGC-1α transcriptional factors in skeletal muscle
Jung, S., & Kim, K. (2014) · Integrative Medicine Research · doi:10.1016/j.imr.2014.09.004 · Cited by 76
Khader, A., Yang, W.-L., Kuncewitch, M., Jacob, A., Prince, J. M., Asirvatham, J. R., Nicastro, J. M., Coppa, G. F., & Wang, P. (2014) · Transplantation · doi:10.1097/tp.0000000000000194 · Cited by 79
Mukwevho, E., Kohn, T. A., Lang, D., Nyatia, E., Smith, J., & Ojuka, E. O. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2007 · Cited by 75
Southgate, R. J., Bruce, C. R., Carey, A. L., Steinberg, G. R., Walder, K., Monks, R., Watt, M. J., Hawley, J. A., Birnbaum, M. J., & Febbraio, M. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3993fje · Cited by 74
RetractedThe effects of short-chain fatty acids on the cardiovascular system
Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J., & Folkerts, G. (2016) · PharmaNutrition · doi:10.1016/j.phanu.2016.02.001 · Cited by 82
The role of CaMKII in regulating GLUT4 expression in skeletal muscle
Ojuka, E. O., Goyaram, V., & Smith, J. A. H. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00091.2012 · Cited by 89
Clark, J., Silvaggi, J. M., Kiselak, T., Zheng, K., Clore, E. L., Dai, Y., Bass, C. E., & Simon, D. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048925 · Cited by 70
Roles of JUMONJI in mouse embryonic development
Jung, J., Mysliwiec, M. R., & Lee, Y. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20204 · Cited by 79
“The MEF2 activities are inhibited by twist, a bHLH protein that is specifically expressed in the mesoderm (Spicer et al., 1996), activated Notch (Wilson-Rawls et al., 1999) and HDAC, a general transcriptional repressor (Zhang et al., 2002; Czubryt et al., 2003).”
BackgroundCzubryt, M. P., & Olson Eric, N. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.105 · Cited by 89
“Examination of the PGC-1 promoter revealed the existence of two putative MEF2 binding sites, which we confirmed did, in fact, bind MEF2 specifically and conferred MEF2 and HDAC5 regulation to a luciferase reporter under control of the PGC-1 promoter (Czubryt et al., 2003).”
BackgroundSelf-citationIKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism
Bakkar, N., Ladner, K., Canan, B. D., Liyanarachchi, S., Bal, N. C., Pant, M., Periasamy, M., Li, Q., Janssen, P. M. L., & Guttridge, D. C. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201108118 · Cited by 69
“Relatively little is known about what controls PGC-1 gene expression or other mitochondrial regulators, although some myogenic factors have been identified (Czubryt et al., 2003; Chang et al., 2006).”
Anderson, K. A., Lin, F., Ribar, T. J., Stevens, R. D., Muehlbauer, M. J., Newgard, C. B., & Means, A. R. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1299 · Cited by 75
“Anti-CaMKK (BD Biosciences, Palo Alto, CA; catalog no. 610545) was used at a dilution of 1:500, antiphospho-HDAC4(ser246)/HDAC5 (ser259)/HDAC7(ser155) (Cell Signaling Technology, Danvers, MA; catalog no. 3443) was used at 1:1000, antiphospho-HDAC4(ser632)/HDAC5(ser498)/HDAC7(ser486) (CellSignaling;catalogno.3424)wasus…”
InfluentialDu, X., Lu, F. Y., & Kiriazis, H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.016 · Cited by 84
Transgenesis and cardiac energetics: new insights into cardiac metabolism
Ingwall, J. S. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.020 · Cited by 69
Zhang, Y., Uguccioni, G., Ljubicic, V., Irrcher, I., Iqbal, S., Singh, K., Ding, S., & Hood, D. A. (2014) · Physiological Reports · doi:10.14814/phy2.12008 · Cited by 67
“The underlying cause of PGC-1a mRNA induction is likely linked to a transcriptional mechanism (Herzig et al. 2001; Czubryt et al. 2003; Daitoku et al. 2003; Akimoto et al. 2004, 2005), since direct measurements of PGC-1a transcription indicated a coincident increase along with the mRNA.”
BackgroundCzubryt, M. P., Espira, L., Lamoureux, L., & Abrenica, B. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-151 · Cited by 82
Self-citationRole of calcineurin in striated muscle: development, adaptation, and disease
Bassel‐Duby, R., & Olson, E. N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.020 · Cited by 71
Self-citationKotelnikova, E. A., Shkrob, M., Pyatnitskiy, M. A., Ferlini, A., & Daraselia, N. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002365 · Cited by 70
Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 Myoblasts
Takemori, H., HASHIMOTO, Y. K., Nakae, J., Olson, E. N., & Okamoto, M. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-173 · Cited by 69
Self-citationChen, J., Shi, X., Padmanabhan, R., Wang, Q., Wu, Z., Stevenson, S. C., Hild, M., Garza, D., & Li, H. (2007) · Genome Research · doi:10.1101/gr.6940108 · Cited by 72
“Previously, mammalian HDAC5 was shown to negatively regulate mitochondrial biogenesis in cells, and mammalian HDAC7 has been reported to have a mitochondrial localization (Czubryt et al. 2003; Bakin and Jung 2004).”
BackgroundGeneration of conditionalMef2cloxP/loxP mice for temporal- and tissue-specific analyses
Vong, L. H., Ragusa, M. J., & Schwarz, J. J. (2005) · genesis · doi:10.1002/gene.20152 · Cited by 63
“…to play roles in calcium signaling, metabolism, immediate-early gene expression, neuronal survival, and T-cell apoptosis (Woronicz et al., 1995; Black and Olson, 1998; Thai et al., 1998; Mao et al., 1999; Youn et al., 1999, 2000; Blaeser et al., 2000; Mora and Pessin, 2000; Czubryt et al., 2003).”
BackgroundBai, Y., Wu, J., Yang, Z., Wang, X., Zhang, D., & Ma, J. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09716-2 · Cited by 67
Metabolic Changes Associated With Muscle Expression of SOD1G93A
Dobrowolny, G., Lepore, E., Martini, M., Barberi, L., Nunn, A., Scicchitano, B. M., & Musarò, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00831 · Cited by 67
“A key regulator of PGC-1α expression is Mef2c, a transcriptional factor that is responsible for fast-to-slow switch of muscle fibers (Czubryt et al., 2003).”
BackgroundGrilo, L. F., Tocantins, C., Diniz, M. S., Gomes, R. M., Oliveira, P. J., Matafome, P. N., & Pereira, S. P. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13625 · Cited by 69
Lysine deacetylases and mitochondrial dynamics in neurodegeneration
Guedes-Dias, P., & Oliveira, J. M. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.005 · Cited by 65
Akimoto, T., Li, P., & Yan, Z. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2008 · Cited by 60
Mercy, L., Pauw, A. D., Payen, L., Tejerina, S., Houbion, A., Demazy, C., Raes, M., Renard, P., & Arnould, T. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04913.x · Cited by 58
Dalziel, A. C., Moore, S. E., & Moyes, C. D. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00152.2004 · Cited by 68
Alamdari, N., Smith, I. J., Aversa, Z., & Hasselgren, P.-O. J. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00858.2009 · Cited by 62
Camerino, G. M., Cannone, M., Giustino, A., Massari, A. M., Capogrosso, R. F., Cozzoli, A., & Luca, A. D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu287 · Cited by 61
Identification and characterization of an alternative promoter of the human PGC-1α gene
Yoshioka, T., Inagaki, K., Noguchi, T., Sakai, M., Ogawa, W., Hosooka, T., Iguchi, H., Watanabe, E., Matsuki, Y., Hiramatsu, R., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.077 · Cited by 65
The A-kinase anchor protein AKAP121 is a negative regulator of cardiomyocyte hypertrophy
Abrenica, B., AlShaaban, M. A., & Czubryt, M. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.018 · Cited by 60
Self-citationMartins, K. J. B., St‐Louis, M., Murdoch, G. K., MacLean, I. M., McDonald, P., Dixon, W. T., Putman, C. T., & Michel, R. N. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.223370 · Cited by 60
“PGC1α is induced by various upstream signals, such as p38-MAPK (Akimoto et al. 2005; Wright et al. 2007), CaMK and calcineurin (Handschin et al. 2003), and possibly MEF2 (Czubryt et al. 2003; Vissing et al. 2008).”
BackgroundHistone deacetylase signaling in cardioprotection
Lehmann, L., Worst, B. C., Stanmore, D. A., & Backs, J. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1516-9 · Cited by 65
Handschin, C. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799891003641074 · Cited by 56
Mughal, W., Nguyen, L., Pustylnik, S., da Silva Rosa, S. C., Piotrowski, S., Chapman, D., Du, M., Alli, N. S., Grigull, J., Halayko, A. J., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.306 · Cited by 56
Potthoff, M. J., Olson, E. N., & Bassel‐Duby, R. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282efb761 · Cited by 61
Self-citationLinking epigenetics to lipid metabolism: Focus on histone deacetylases
Ferrari, A., Fiorino, E., Giudici, M., Gilardi, F., Galmozzi, A., Mitro, N., Cermenati, G., Godio, C., Caruso, D., Fabiani, E. D., et al. (2012) · Molecular Membrane Biology · doi:10.3109/09687688.2012.729094 · Cited by 64
“Furthermore, several studies revealed that HDACs, in particular HDAC4 and HDAC5, regulate the expression of metabolic genes in skeletal muscle (Czubryt et al. 2003, Potthoff et al. 2007, McGee et al. 2008).”
BackgroundBao, L., Cai, X., Dai, X., Ding, Y., Jiang, Y., Li, Y., Zhang, Z., & Li, Y. (2014) · Food & Function · doi:10.1039/c4fo00340c · Cited by 55
The secret messages between mitochondria and nucleus in muscle cell biology
Soledad, R. B., Charles, S., & Das, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.03.019 · Cited by 55
“The transcription factor MEF2 (Myocyte Enhancing Factor 2) has been described as a regulator of genes, such as glucose transporter 4 (GLUT4) [54], troponin I type 1 (a component of slow muscle fibers) [55] and PGC-1α [56] in skeletal muscle.”
BackgroundHu, X., Xu, X., Huang, Y., Fassett, J., Flagg, T. P., Zhang, Y., Nichols, C. G., Bache, R. J., & Chen, Y. (2008) · Circulation Research · doi:10.1161/circresaha.107.170795 · Cited by 54
The Impact of Skeletal Muscle ERα on Mitochondrial Function and Metabolic Health
Hevener, A. L., Ribas, V., Moore, T. M., & Zhou, Z. (2020) · Endocrinology · doi:10.1210/endocr/bqz017 · Cited by 54
Cyclin-Dependent Kinase-9: An RNAPII Kinase at the Nexus of Cardiac Growth and Death Cascades
Sano, M., & Schneider, M. D. (2004) · Circulation Research · doi:10.1161/01.res.0000146675.88354.04 · Cited by 54
Sparling, D. P., Griesel, B. A., Weems, J., & Olson, A. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800481200 · Cited by 53
Class II Histone Deacetylases Limit GLUT4 Gene Expression during Adipocyte Differentiation
Weems, J. C., & Olson, A. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157107 · Cited by 57
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 61
Li, J., Wang, Z., Li, C., Song, Y., Wang, Y., Hai, B., & Zhang, Y. (2022) · Cells · doi:10.3390/cells11132086 · Cited by 65
Wang, H., Peiris, T. H., Mowery, A., Le Lay, J., Gao, Y., & Greenbaum, L. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0388 · Cited by 52
HDAC4 Regulates Muscle Fiber Type-Specific Gene Expression Programs
Cohen, T. J., Choi, M., Kapur, M., Lira, V. A., Yan, Z., & Yao, T. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.2278 · Cited by 57
“Promoter analysis and cell-based studies have identified MEF2 as a key transcriptional activator for PGC-1α expression in skeletal muscle (Akimoto et al., 2004b; Czubryt et al., 2003).”
BackgroundMcGee, S. L., Swinton, C., Morrison, S., Gaur, V., Campbell, D. E., Jorgensen, S. B., Kemp, B. E., Baar, K., Steinberg, G. R., & Hargreaves, M. (2014) · The FASEB Journal · doi:10.1096/fj.14-249359 · Cited by 52
“Previous studies in the heart have established the importance of HDAC5 phosphorylation for the maintenance of metabolic and mitochondrial gene expression (35), yet the specific role for HDAC5 phosphorylation in the regulation of metabolism had not been”
BackgroundOptimizing training adaptations by manipulating glycogen
Baar, K., & McGee, S. (2008) · European Journal of Sport Science · doi:10.1080/17461390801919094 · Cited by 51
“In the heart, mutation of ser259 and ser498 on HDAC4, the key residues regulating HDAC function, results in sudden death due to cardiac mitochondrial abnormalities secondary to reduced expression of PGC-1a and many mitochondrial enzymes (Czubryt et al., 2003).”
BackgroundWang, X., Wei, X., Pang, Q., & Yi, F. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.005 · Cited by 59
Feng, Z., Zhou, J., Li, Q., Chu, L., Jiang, Y., Zhang, X., Yan, L., Liu, Y., Jiang, J. H., Xu, P., et al. (2023) · Theranostics · doi:10.7150/thno.82552 · Cited by 54
Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells
Raichur, S., Teh, S. H., Ohwaki, K., Gaur, V., Long, Y. C., Hargreaves, M., McGee, S. L., & Kusunoki, J. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0095 · Cited by 57
“Supporting this are experiments showing that cardiac expression of mutantHDAC5 that cannot be phosphorylated suppressed numerous metabolic genes, including those involved in glucose, fatty acid and oxidative metabolism (Czubryt et al. 2003).”
BackgroundInfluentialHistone modifications and skeletal muscle metabolic gene expression
McGee, S. L., & Hargreaves, M. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05311.x · Cited by 50
“Furthermore, overexpression of HDAC5 in the heart leads to a decrease in the expression of genes involved in substrate handling and energy production, including PGC-1a, carnitine palmatoyl transferase 1, hexokinase II, glycogen phopshorylase and medium chain acyl-CoA dehydrogenase to name a few.(17) Furthermore, mice…”
BackgroundHan, D.-H., Nolte, L. A., Ju, J.-S., Coleman, T., Holloszy, J. O., & Semenkovich, C. F. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2003 · Cited by 49
“Although MEF2 has been implicated as a mediator of energy flux in muscle (9), chemical activation of AMP kinase causes a coordinate induction of MEF2A, MEF2D, and GLUT4 in myocytes (30).”
BackgroundCoordination of cytochrome c oxidase gene expression in the remodelling of skeletal muscle
Duggan, A. T., Kocha, K. M., Monk, C. T., Bremer, K., & Moyes, C. D. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.053322 · Cited by 52
“For the genes encoding proteins of OXPHOS complexes, including COX, two DNA-binding proteins (NRF-1, NRF-2) and the coactivator PGC-1 are paramount in coordinating expression (Czubryt et al., 2003; Puigserver and Spiegelman, 2003; Wu et al., 1999).”
BackgroundZhang, M., Jiang, Y., Guo, X., Zhang, B., Wu, J., Sun, J., Liang, H., Shan, H., Zhang, Y., Liu, J., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14641 · Cited by 51
Targeting PGC-1α to control energy homeostasis
Wu, Z., & Boss, O. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1329 · Cited by 48
“Several other transcription factors, including MADS box transcription enhancer factor 2, ERR- α and ERR- γ , similarly increase PGC-1 α transcription in a tissue-specific manner [8,49] .”
BackgroundRegulation of PGC-1α Isoform Expression in Skeletal Muscles
Popov, D. V., Lysenko, E. A., Kuzmin, I. V., Виноградова, О. Л., & Grigoriev, A. I. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-1-48-59 · Cited by 60
Bruserud, Ø., Stapnes, C., Tronstad, K. J., Ryningen, A., Ånensen, N., & Gjertsen, B. T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.51 · Cited by 49
Metadata
- Authors
- Czubryt, M. P., McAnally, J., Fishman, G. I., & Olson, E. N.
- Affiliations
- New York University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-02-10
- Volume
- 100
- Issue
- 4
- Pages
- 1711-1716
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC149898
- OpenAlex
- W2036834412
- Cited by
- 418
- References
- 30
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 12 · 2023: 15 · 2022: 21 · 2021: 8 · 2020: 13 · 2019: 15 · 2018: 17 · 2017: 15 · 2016: 15 · 2015: 18 · 2014: 20 · 2013: 19 · 2012: 32
- FWCI
- 13.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- PGC-1α, MEF2, HDAC5, class II histone deacetylases, cardiac mitochondrial function, mitochondrial biogenesis, sudden cardiac death, transcriptional repression, calcium signaling, heart
- MeSH terms
- Acetylation, Animals, Base Sequence, DNA-Binding Proteins, Gene Expression Regulation, Histone Deacetylases, Histones, Mice, Transgenic, Mitochondria, Heart, Transcription Factors, Death, Sudden, Cardiac, DNA Primers, Myogenic Regulatory Factors, DNA, Complementary, COS Cells, Electrophoretic Mobility Shift Assay, Mice, MEF2 Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.